➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: August 5, 2021

DrugPatentWatch Database Preview

Patent: 10,047,403

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,047,403
Title:Diagnostic methods for determining prognosis of non-small cell lung cancer
Abstract: The present disclosure provides methods for identifying early stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods are based in part on the discovery of chromosomal copy number abnormalities that can be used for prognostic classification. The methods preferably use fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the chromosomal copy number of these genetic loci.
Inventor(s): Semizarov; Dimitri (Chicago, IL), Lu; Xin (Libertyville, IL), Zhang; Ke (Grand Forks, ND), Lesniewski; Rick R. (Collegeville, PA), Coon; John S. (Oak Park, IL)
Assignee: Abbott Molecular Inc. (Des Plaines, IL)
Application Number:15/019,829
Patent Claims:see list of patent claims

Details for Patent 10,047,403

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10 ⤷  Try it Free Abbott Molecular Inc. (Des Plaines, IL) 2029-10-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,047,403

Country Patent Number Estimated Expiration
South Africa 201203010 ⤷  Try it Free
South Africa 201203011 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 2011056489 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 2011056490 ⤷  Try it Free
World Intellectual Property Organization (WIPO) 2011056505 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.